This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

J. LAWTON SMITH, MD
Bascom Palmer Eye Institute Miami, Fla

JAMA. 1975;231(9):916.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

I read with interest in the QUESTIONS AND ANSWERS section (230:1202, 1974) the note entitled "What Risk to Fetus from Maternal Steroid Therapy." A 33-year-old woman had acute thyrotropic exophthalmos with euthyroidism in the fifth month of pregnancy. She required large doses of steroids to control her eye problem, and was given prednisone, 100 mg/day, orally. The question of risks to the fetus was raised, and the follow-up note reported that the patient did have a child who had hydrocephalus requiring surgery at 2 months of age.

I should like to point out that this patient was an ideal candidate to have been treated with steroids administered in the sub-tenon space. A single injection of triamcinolone acetonide (Kenalog), 40 mg/ml to both orbits, would have controlled her eye problem for two to six weeks, in my experience, and would have totally obviated the necessity for maintaining her . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?